Evaluation of the Bosphore HBV Quantification Kit: Categorical and Quantitative Agreement with the Aptima HBV Quant Assay for HBV DNA Detection and Quantification
Microorganisms · 01.11.2026 · 14 (11) · 2489
DOI: 10.3390/microorganisms14112489 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 01.11.2026. Verfasst von Massimiliano Guerra und 13 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Accurate hepatitis B virus (HBV) DNA quantification is essential for assessing viral replication and monitoring antiviral therapy. This retrospective method-comparison study evaluated the Bosphore HBV Quantification Kit against the Aptima HBV Quant Assay using 130 residual anonymized EDTA-plasma specimens, comprising 110 comparator-positive and 20 comparator-negative samples. Categorical agreement was assessed using positive, negative, and overall percent agreement (PPA, NPA, and OPA), while quantitative agreement was evaluated using a predefined ±0.5 log10 IU/mL criterion, Bland–Altman analysis, Passing–Bablok regression, and Lin’s concordance correlation coefficient (CCC). PPA was 100% (110/110; 95% confidence interval [CI], 96.70–100.00%), NPA was 95.0% (19/20; 95% CI, 75.13–99.87%), and OPA was 99.23% (129/130; 95% CI, 95.79–99.98%). One confirmed qualitative discordance was observed. Overall, 109/110 paired numerical results (99.1%; 95% CI, 95.04–99.98%) were within ±0.5 log10 IU/mL. Bland–Altman analysis showed a mean bias of +0.124 log10 IU/mL, Passing–Bablok regression yielded Y = 0.107 + 1.019X, and Lin’s CCC was 0.991. The Bosphore assay demonstrated high categorical and quantitative agreement with the comparator across the HBV DNA concentration range evaluated, supporting its potential suitability for quantitative HBV DNA testing within the analytical workflow assessed in this study.
Zitieren
APA
Guerra, M., Dionisi, L., Colosimo, C., Pascali, A. M. D., Brandolini, M., Ingletto, L., Montanari, M. S., Grumiro, L., Gatti, G., Dirani, G., Zannoli, S., Scagliarini, A., Cricca, M., & Sambri, V. (2026). Evaluation of the Bosphore HBV Quantification Kit: Categorical and Quantitative Agreement with the Aptima HBV Quant Assay for HBV DNA Detection and Quantification. Microorganisms, 14(11), 2489. https://doi.org/10.3390/microorganisms14112489
Vancouver
Guerra M, Dionisi L, Colosimo C, Pascali AMD, Brandolini M, Ingletto L, et al. Evaluation of the Bosphore HBV Quantification Kit: Categorical and Quantitative Agreement with the Aptima HBV Quant Assay for HBV DNA Detection and Quantification. Microorganisms. 2026;14(11):2489. doi:10.3390/microorganisms14112489
BibTeX
@article{Guerra2026,
author = {Guerra, Massimiliano and Dionisi, Laura and Colosimo, Claudia and Pascali, Alessandra Mistral De and Brandolini, Martina and Ingletto, Ludovica and Montanari, Maria Sofia and Grumiro, Laura and Gatti, Giulia and Dirani, Giorgio and Zannoli, Silvia and Scagliarini, Alessandra and Cricca, Monica and Sambri, Vittorio},
title = {Evaluation of the Bosphore HBV Quantification Kit: Categorical and Quantitative Agreement with the Aptima HBV Quant Assay for HBV DNA Detection and Quantification},
journal = {Microorganisms},
year = {2026},
volume = {14},
number = {11},
pages = {2489},
doi = {10.3390/microorganisms14112489}
}
EUVIMED